IMPILO HEALTHCARE HOLDING AB
IMPILO HEALTHCARE HOLDING AB is a Series C+ and buyout fund in the US, Nordics and Europe writing $50M–$200M checks into Healthcare, healthcare-tech, pharmaceuticals and health-services.
- Stages
- Series C+, buyout
- Sectors
- Healthcare, healthcare-tech, pharmaceuticals, health-services
- Check size
- $50M–$200M
- Invests in
- US-wide, Nordics, Europe
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2017
- Assets under management
- €2B
Thesis
Impilo Healthcare Holding AB is a Stockholm-based private equity firm exclusively focused on the healthcare sector, primarily in the Nordic region, with a mandate to "invest in a healthy future." They target companies with enterprise values between €50 million and €200 million, focusing on buyouts and growth capital for businesses in pharmaceuticals, MedTech, and health services. Their investment framework, the "Impilo Health Diamond," emphasizes improving care quality, availability, and affordability, while integrating ESG considerations. Fund II closed at €700 million, and the firm manages approximately €2 billion in capital. They look for companies with the potential to double operating profit over five years and outgrow their markets. While primarily focused on the Nordics, up to 25% of commitments can be invested in other European countries and North America. The firm was founded in 2017.
Common questions
Does IMPILO HEALTHCARE HOLDING AB invest at the Series C+ stage?
Yes. IMPILO HEALTHCARE HOLDING AB lists Series C+ and buyout among the stages it invests in.
What check size does IMPILO HEALTHCARE HOLDING AB write?
IMPILO HEALTHCARE HOLDING AB writes $50M–$200M checks.
Where does IMPILO HEALTHCARE HOLDING AB invest?
IMPILO HEALTHCARE HOLDING AB invests in the US, Nordics and Europe.